menu
Embolization Market Restraints, Analysis and Forecast 2020-2027
Embolization Market Restraints, Analysis and Forecast 2020-2027
The global embolization market is estimated to be valued at US$ 1,433.6 million in 2020 and is expected to exhibit a CAGR of 8.1% over the forecast period (2020-2027).

When the FDA's (Food and Drug Administration) laws are broken by manufacturers and distributors, a voluntary product recall is initiated. The action is being taken to safeguard the public from injury. The market's expansion is projected to be hampered by an increasing number of embolization product recalls by various inventors and manufacturers.

Embolization is a very common and effective procedure in interventional radiology.  Medtronic Plc, for example, recalled the Pipeline Flex Embolization Device (sold in the United States) and the Pipeline Flex Embolization Device with Shield Technology in March 2020. The reason for the recall is that there is a possibility that the delivery system would fracture when inserting the stent inside the patient.

Benefits of Embolization-

·        It is highly effective at stopping bleeding.

·        It's less invasive - less time in hospital and minimal bleeding.

·        It treats areas that are difficult for surgeons to reach safely.

·        Less damage to the body - one small cut for inserting a catheter.

 

Explore the Complete Report- https://bit.ly/3NBftCK